Synflorix™ receives European marketing authorisation for additional pneumonia indication

GlaxoSmithKline (GSK) today announced that the European Commission (EC) has granted marketing authorisation for an additional indication for Synflorix™.
Source: GSK news - Category: Pharmaceuticals Source Type: news